Impact of SARS-CoV-2 On St-Elevation Myocardial Infarction (STEMI) |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.9, No. 1)Publication Date: 2020-05-26
Authors : Fatemeh Sadat Mahdavi; Armin Khavandegar; Parham Mardi;
Page : 73-75
Keywords : Respiratory; Syndrome; Corona Virus; Chronic bronchitis; congestive heart diseases;
Abstract
Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV 2) pandemic originated from Wuhan, China, in December 2019 and rapidly spread throughout the globe [1]. Currently, SARS-CoV 2 has resulted in an enormous number of deaths worldwide [2,3]. Based on the WHO report on 28 April 2020, almost 3 million confirmed cases of COVID-19 have been identified, and nearly 7% of them have died due to disease and its complications [4]. Regarding the catastrophic impact of COVID-19 on human well-being, investigation of its manifestations, complications, and appropriate treatment has become the most concerning issue in the World Health Organization recently.
Other Latest Articles
- Is Bevacizumab a Direct Cause of Osteonecrosis of the Jaw like Bisphosphonate? |Biomedgrid
- Evidence based study of Hypoglycemic Potential of Bitter Melon Peptide |Biomedgrid
- Improving Urban Resilience through Formal Integration of Waste Pickers in Jordan’s Solid Waste Management
- COVID impact on usage of public spaces in Brasilia, Brazil
- What is the general population’s perception of smart motorways in the UK?
Last modified: 2023-06-14 21:00:59